GenMark Diagnostics (GNMK) Tops Q3 EPS by 4c

GenMark Diagnostics (NASDAQ: GNMK) reported Q3 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $8.8 million versus the consensus estimate of $8.24 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform